GlassScriptPhysician profile
Yong Tang
NPI 1093913527
$17,699.60
in general payments reported to CMS, 2019-2025
88 companies · $3,897 in 2025
The $3,897 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,758 · 2020: $441 · 2021: $1,401 · 2022: $2,716 · 2023: $3,728 · 2024: $3,757 · 2025: $3,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $46.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,336.07 |
| Education | $46.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,435.30 | 2019-2025 | Erleada, Tecvayli, Darzalex |
| Astrazeneca Pharmaceuticals LP | $1,404.26 | 2019-2025 | Calquence, Imfinzi, Onglyza |
| Incyte Corporation | $796.99 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Pfizer INC. | $796.81 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $663.98 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $615.80 | 2019-2025 | Ninlaro, Iclusig, Fruzaqla |
| Gilead Sciences, INC. | $590.64 | 2021-2025 | Trodelvy |
| E.R. Squibb & Sons, L.L.C. | $587.67 | 2019-2025 | Opdivo, Augtyro |
| Amgen INC. | $546.59 | 2019-2025 | Imdelltra (Amg757), Kyprolis, Lumakras |
| Celgene Corporation | $493.19 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Genentech USA, INC. | $492.02 | 2019-2025 | Lunsumio, Columvi, Polivy |
| Merck Sharp & Dohme LLC | $456.38 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Genzyme Corporation | $391.87 | 2019-2025 | |
| Astellas Pharma US INC | $327.97 | 2020-2024 | Padcev, Xtandi, Vyloy |
| Glaxosmithkline, LLC. | $327.80 | 2020-2025 | Ojjaara, Zejula, Jemperli |
Show all 88 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $323.69 | 2019-2025 | Quzyttir, Xermelo, Zoladex |
| Eisai INC. | $319.23 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $297.03 | 2020-2025 | |
| Daiichi Sankyo INC. | $266.13 | 2019-2025 | Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.41 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $240.53 | 2019-2025 | Ultomiris |
| Exelixis INC. | $226.74 | 2021-2025 | Cabometyx |
| Abbvie INC. | $226.46 | 2021-2025 | Venclexta |
| Pharmacyclics LLC, An Abbvie Company | $222.52 | 2019-2023 | Imbruvica, Epkinly |
| Aveo Pharmaceuticals, INC. | $210.54 | 2022-2025 | Fotivda |
| Regeneron Healthcare Solutions, INC. | $206.93 | 2021-2025 | Libtayo |
| Mirati Therapeutics, INC. | $206.41 | 2023-2024 | Krazati |
| Alnylam Pharmaceuticals INC. | $204.04 | 2022-2025 | Givlaari, Amvuttra |
| Array Biopharma INC | $203.09 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Pharmacosmos Therapeutics INC. | $202.38 | 2021-2025 | Monoferric |
| Sobi, INC | $201.65 | 2022-2025 | |
| Emd Serono, INC. | $178.59 | 2019-2025 | Tepmetko |
| Kite Pharma, INC. | $178.14 | 2020-2025 | Yescarta |
| Pharmaessentia USA Corporation | $162.86 | 2024-2025 | Besremi |
| Taiho Oncology, INC. | $161.55 | 2019-2025 | |
| Seagen INC. | $159.08 | 2019-2023 | Tivdak |
| Deciphera Pharmaceuticals INC. | $151.72 | 2020-2025 | Qinlock, Tgct, Romvimza |
| Lilly USA, LLC | $141.69 | 2019-2024 | Jaypirca, Retevmo, Verzenio |
| Janssen Pharmaceuticals, INC | $138.89 | 2019-2024 | Xarelto |
| Genmab U.S., INC. | $134.22 | 2023-2024 | Epkinly |
| Karyopharm Therapeutics INC. | $121.08 | 2022-2025 | Xpovio |
| Coherus Oncology, INC. | $114.34 | 2022-2024 | |
| Novocure INC. | $114.27 | 2024-2025 | Optune Gio, Optune, Optune Lua (Novottf-200t) |
| Rigel Pharmaceuticals, INC. | $108.23 | 2022-2024 | Tavalisse, Rezlidhia |
| Ipsen Biopharmaceuticals, INC | $107.13 | 2019-2024 | Tazverik, Onivyde, Somatuline Depot |
| Acrotech Biopharma INC. | $105.28 | 2021-2025 | Beleodaq |
| Morphosys, US INC. | $97.95 | 2021-2023 | Monjuvi |
| Adc Therapeutics America, INC. | $94.99 | 2022-2024 | |
| Geron Corporation | $89.60 | 2025 | Rytelo |
| Agios Pharmaceuticals, INC. | $86.01 | 2021-2025 | Pyrukynd |
| Beone Medicines USA, INC. | $82.92 | 2025 | Tevimbra, Brukinsa |
| Puma Biotechnology, INC. | $73.05 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $69.30 | 2023-2025 | Avastin, Alymsys |
| Blueprint Medicines Corporation | $69.05 | 2022-2024 | Ayvakit |
| Stemline Therapeutics INC. | $68.65 | 2023-2025 | Orserdu, Elzonris |
| G1 Therapeutics, INC. | $68.36 | 2022-2023 | Cosela |
| Kyowa Kirin, INC. | $66.02 | 2023-2025 | Poteligeo |
| Myovant Sciences INC. | $63.65 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $60.63 | 2024-2025 | Danziten, Triptodur |
| Foundation Medicine, INC. | $60.21 | 2022-2023 | Foundationone Liquid Cdx |
| Recordati_rare_diseases_inc. | $59.69 | 2024-2025 | Sylvant |
| Beigene USA, INC. | $56.47 | 2022-2024 | Tevimbra |
| Eusa Pharma (US) LLC | $49.23 | 2021 | |
| Adaptive Biotechnologies Corporation | $48.21 | 2022-2025 | Clonoseq |
| Fennec Pharmaceuticals, INC. | $47.66 | 2025 | Fyarro |
| Organon LLC | $47.45 | 2024 | |
| Tactile Systems Technology INC | $40.42 | 2024 | Entre Plus, Flexitouch Plus |
| Janssen Scientific Affairs, LLC | $34.01 | 2023 | Darzalex, Tecvayli |
| Celltrion USA INC. | $32.11 | 2023 | Vegzelma |
| Syndax Pharmaceuticals, INC. | $29.11 | 2025 | |
| Amag Pharmaceuticals, INC. | $29.11 | 2020-2022 | |
| Iovance Biotherapeutics, INC. | $28.80 | 2025 | Amtagvi |
| Sun Pharmaceutical Industries INC. | $25.02 | 2025 | |
| Immunogen, INC. | $24.95 | 2023 | Elahere |
| Tg Therapeutics, INC. | $24.79 | 2021 | |
| Lundbeck LLC | $24.60 | 2024 | Vyepti |
| Servier Pharmaceuticals LLC | $24.58 | 2025 | |
| Spectrum Pharmaceuticals INC. | $23.08 | 2025 | Rolvedon |
| Accord Healthcare, INC. | $23.07 | 2024 | |
| Curium US LLC | $23.02 | 2024 | Detectnet |
| Myriad Genetic Laboratories, INC. | $19.00 | 2024 | Myrisk |
| Tempus Ai, INC | $18.59 | 2024 | Xt Cdx |
| Heron Therapeutics, INC. | $18.58 | 2023 | Sustol |
| Biocon Biologics INC | $16.16 | 2025 | Ogivri |
| Lexicon Pharmaceuticals, INC. | $15.25 | 2019 | |
| Aurobindo Pharma USA, INC. | $15.09 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.04 | 2024 | Xtampza |
| Nestle Healthcare Nutrition INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
Trodelvy $380Erleada $379Tecvayli $361Jakafi $339Darzalex $307Calquence $304Xtandi $300Keytruda $242Monjuvi $235Epkinly $229Imfinzi $226Imbruvica $212Nubeqa $212Lenvima $208Pluvicto $208Krazati $206Talzenna $205Opdivo $203Sarclisa $200Talvey $196Monoferric $178Akeega $177Reblozyl $175Inlyta $170Fotivda $166Cabometyx $165Besremi $163Kisqali $153Ultomiris $150Quzyttir $149Libtayo $144Lynparza $136Ojjaara $134Enhertu $133Orgovyx $132Rybrevant $127Xofigo $126Onglyza $120Givlaari $119Lutathera $107Lonsurf $106Inqovi $106Xpovio $105Lunsumio $104Padcev $103Yescarta $102Imdelltra (Amg757) $100Tevimbra $98.03Niktimvo $97.50Vonjo $95.95Xermelo $95.50Braftovi $94.25Ninlaro $93.87Beleodaq $91.46Rytelo $89.60Adcetris $85.99Elrexfio $85.99Vitrakvi $85.42Stivarga $85.42Opdualag $84.03Pemazyre $82.54Columvi $80.76Polivy $80.76Iclusig $79.88Pomalyst $78.12Optune Gio $75.14Welireg $75.09Rezlidhia $73.91Tavalisse $73.91Tivdak $72.46Mektovi $69.50Qinlock $67.79Bosulif $66.85Udenyca $66.75Pyrukynd $66.68Poteligeo $66.02Zejula $65.44Jaypirca $63.34Avastin $62.87Sylvant $59.69Venclexta $59.52Ibrance $55.89Fruzaqla $53.80Elahere $52.30Tazverik $52.10Alunbrig $50.99Ayvakit $49.20Orserdu $48.75Amvuttra $48.47Fyarro $47.66Ontruzant $47.45Paxlovid $46.81Zynyz $46.81Lorbrena $46.31Danziten $45.87Jemperli $44.79Doptelet $42.71Flexitouch Plus $40.42Entre Plus $40.42Optune $39.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yong Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.